Blood clot formation
Blood clot formation
Blood clots
Blood clots

Congenital protein C or S deficiency

Definition:
These inherited disorders of blood coagulation are caused by deficiency of the Vitamin K-dependent plasma proteins C or S that are naturally occurring anticoagulants. The disorder results in an increased tendency for intravascular blood clot formation.

Causes, incidence, and risk factors:

Congenital protein C or S deficiency is an inherited disorder that causes abnormal blood clotting. Normal blood coagulation is a complex process involving as many as 20 different plasma proteins which are known as blood coagulation factors.

A series of complex chemical reactions using these factors takes place very rapidly to form an insoluble protein called fibrin that stops bleeding. Other plasma proteins, such as proteins C and S inhibit or reverse the cascade to prevent excessive clotting.

When certain coagulation factors are deficient or missing, the chain reaction does not take place normally. In this disorder, an increased risk of blood clot formation called thrombosis is present. Risk factors are an individual or family history of recurrent blood clots in the veins.

There are different types of genetic transmission of this disease. Heterozygous (one normal gene and one defective) protein C deficiency occurs in approximately 1 in 300 members of the general population. Protein S deficiency occurs in 1 out of 20,000 people.

Symptoms:
  • Pain or tenderness in extremity or affected area
  • Redness or swelling in affected area
Note: Symptoms, if present, will be the same as for deep venous thrombosis.
Signs and tests:
Treatment:
Treatment for deep venous thrombosis includes therapy with heparin and warfarin. Warfarin is usually given preventatively after a first clotting episode in patients identified to have this disorder.
Expectations (prognosis):
The outcome is usually good with treatment, but recurrences can occur.
Complications:
  • Pulmonary embolism.
  • Recurrent venous clots.
  • Childhood stroke.
  • In rare cases, initial anticoagulation with warfarin can cause transient increased coagulation with severe skin lesions. Patients are at risk if not adequately anticoagulated with heparin prior to taking warfarin.
Calling your health care provider:
Call your health care provider if symptoms develop that are suggestive of intravenous clotting (i.e., swelling and redness of the leg).
Prevention:
If the disorder is diagnosed, precautions may be taken to avoid thrombus formation in high-risk situations that promote slow movement of the blood in the veins. This occurs with prolonged bed rest usually as a result of an illness, surgery, or hospitalization.

Review Date: 10/14/2001
Reviewed By: Rebecca Elstrom, M.D., Division of Hematology-Oncology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.